Hip Replacement Devices Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product Type (Primary Hip Reconstruction Devices, Partial Hip Reconstruction Devices, Revision Hip Reconstruction Devices, Hip Resurfacing Devices), By End User (Hospitals, Ambulatory Care Centers, Orthopedics Clinics, Others), By Region, & Competition, 2020-2030F

Market Overview

Global Hip Replacement Devices market was valued at USD 5.78 Billion in 2024 and is expected to reach USD 6.94 Billion by 2030 with a CAGR of 3.05%. The Global Hip Replacement Devices Market is undergoing significant transformation, emerging as a pivotal segment within the orthopedic medical device sector. This evolution is being shaped by a confluence of strategic factors including the accelerating global aging trend, technological advancements in implant design and surgical techniques, and a sharp rise in demand for mobility-enhancing interventions across healthcare systems.

Market momentum is being sustained by the growing procedural volume of hip arthroplasties, coupled with broader access to surgical care and a shift in public health priorities toward active aging and functional independence among older adults. These dynamics are not only reshaping patient care models but also redefining product innovation pipelines across the industry.

The market is expected to maintain a strong growth trajectory, driven by the increasing incidence of degenerative joint conditions, longer life expectancy, and continued investment in precision-based orthopedic solutions. As global health systems place greater emphasis on restoring patient mobility and minimizing disability, hip replacement procedures are poised to remain a strategic area of focus offering robust opportunities for device manufacturers, healthcare providers, and investors seeking to capitalize on this high-value, clinically essential space.

Key Market Drivers

Rising Prevalence of Osteoarthritis and Degenerative Hip Disorders

The Global Hip Replacement Devices Market is experiencing sustained growth due to several powerful market drivers that are reshaping the orthopedic landscape. These drivers are a combination of demographic, technological, and healthcare system-related factors that together create a strong demand environment for hip replacement procedures and devices. In 2020, approximately 595 million individuals worldwide were living with osteoarthritis, accounting for 7.6% of the global population. This reflects a 132.2% increase in prevalence since 1990, underscoring the accelerating global burden of joint degeneration. Looking ahead, current projections suggest that the number of osteoarthritis cases will rise by an additional 74.9% by 2050, signaling a significant and ongoing demand driver for orthopedic interventions, particularly hip replacement solutions. The growing incidence of osteoarthritis, rheumatoid arthritis, avascular necrosis, and other degenerative joint diseases is a primary driver fueling demand for hip replacement devices. Osteoarthritis, particularly in aging populations, leads to chronic pain and reduced mobility, often requiring surgical intervention when conservative treatments fail.

According to data from the World Health Organization, symptomatic osteoarthritis affects approximately 9.6% of men and 18% of women aged 60 and above. This gender disparity highlights a disproportionately higher burden among older women and underscores the need for targeted orthopedic solutions particularly hip replacement interventions as the global senior population continues to expand. This increase in disease burden directly correlates with the rising number of primary and revision total hip arthroplasties (THAs) being performed worldwide. The growing patient pool, especially among elderly and active middle-aged populations, is creating a consistent and predictable demand for hip replacement devices across both developed and emerging markets. Breakthrough innovations in implant materials, surgical instrumentation, and minimally invasive procedures are expanding the scope and effectiveness of hip replacement treatments. Advanced biomaterials such as highly cross-linked polyethylene, ceramics, and porous titanium offer improved biocompatibility, reduced wear rates, and enhanced implant longevity. Modern implant designs allow for better anatomical fit, faster recovery times, and improved patient mobility. The adoption of robotic-assisted surgeries, navigation systems, and computer-guided techniques is improving surgical accuracy, reducing intraoperative errors, and minimizing complications. Technological progress not only enhances clinical outcomes and surgeon confidence but also increases procedure volumes by making hip replacement more appealing to both patients and providers. Innovation also provides manufacturers with product differentiation in a competitive market.

Expanding Geriatric Population Globally

As people age, they naturally experience progressive musculoskeletal wear and tear, particularly in weight-bearing joints such as the hip. Chronic pain is notably widespread among older adults, with studies indicating that between 27% and 60% of individuals over the age of 65 suffer from persistent pain conditions. The geriatric population represents the largest and most predictable consumer base for hip replacement devices. As this demographic expands globally, the demand for primary hip arthroplasty procedures will continue to grow at a steady pace, ensuring consistent revenue streams for manufacturers. Global life expectancy has seen a remarkable transformation rising from an average of just 32 years to approximately 73 years by 2023, marking a 41-year increase. While this longevity gain reflects major advancements in healthcare and living conditions, the pace of improvement has begun to decelerate. More importantly, the gap between overall life expectancy and healthy life expectancy is widening, indicating that individuals are living longer but spending more of those additional years managing chronic conditions, including degenerative joint diseases thereby reinforcing the growing demand for interventions like hip replacement surgeries that enhance functional independence in aging populations. These trends are shifting hip replacement from being a procedure of last resort to a proactive lifestyle intervention for seniors. This change is driving up the adoption of high-performance implants, including those designed for durability and long-term wear resistance.

Advances in anesthesia, surgical techniques, and post-operative care have significantly reduced the risks associated with surgery for older patients. Minimally invasive procedures and robotic-assisted surgery have made hip arthroplasty safer and more accessible for elderly individuals who may have comorbid conditions. Improved clinical safety profiles are encouraging physicians to recommend surgery to older patients who would have previously been considered high-risk. As a result, the eligible surgical population within the geriatric group is expanding, directly boosting procedure volumes. Many developed countries are implementing public health programs that subsidize or fully reimburse joint replacement procedures for the elderly. In the U.S., for example, Medicare covers total hip arthroplasty, making it financially feasible for most retired individuals. Emerging economies are also increasing budget allocations for elder care and orthopedic services through universal health coverage initiatives. Supportive reimbursement environments and public policy frameworks are reducing financial barriers for senior patients, increasing procedural uptake and stimulating market demand for both standard and advanced hip implants.

Download Free Sample Report

Key Market Challenges

High Cost of Devices and Surgical Procedures

The total cost of hip replacement including implants, surgical fees, hospitalization, and rehabilitation remains prohibitively high in many regions, limiting access for a large segment of the population.

Premium hip implants made from advanced materials (e.g., ceramic-on-ceramic or 3D-printed titanium) come at a substantially higher cost, making them less accessible in both public and private healthcare settings in developing countries. Out-of-pocket expenses are often substantial, especially in regions with limited insurance penetration or fragmented reimbursement policies. Even in developed markets, payers are exerting downward pressure on pricing, pushing hospitals to limit the use of high-cost implants unless strong clinical justification exists.

This financial barrier reduces patient volume and delays elective surgeries, particularly in middle- and low-income regions. Cost pressures also challenge manufacturers to balance innovation with affordability, slowing the commercialization of next-generation devices.

Regulatory and Approval Complexities

Stringent and region-specific regulatory frameworks make it time-consuming and expensive for companies to bring new hip replacement devices to market.

Approval processes from authorities such as the U.S. FDA, European Medicines Agency (EMA), and China's NMPA require extensive clinical trials and compliance documentation, significantly increasing time-to-market. Post-market surveillance requirements and risk classifications have tightened, especially in the wake of high-profile device recalls, forcing manufacturers to invest more in quality assurance and reporting systems. Inconsistencies across global regulatory standards create duplicative efforts, increasing operational burden for companies aiming to expand internationally.

Regulatory bottlenecks delay innovation cycles and increase R&D and compliance costs. Smaller and mid-sized companies, in particular, face barriers to entry, leading to reduced competitive diversity and slower market evolution.

Key Market Trends

Rapid Advancement in Implant Technologies and Materials

Ongoing innovation in implant design and biomaterials is significantly improving the functionality, durability, and compatibility of hip replacement devices.

Modern implants now incorporate high-performance biomaterials such as highly cross-linked polyethylene, ceramic-on-ceramic articulations, and porous titanium coatings that enhance osseointegration and reduce wear rates. Manufacturers are increasingly integrating 3D printing and custom implants, enabling better anatomical fit and alignment, particularly for patients with complex joint structures or deformities. The adoption of smart implants with embedded sensors to monitor joint performance post-surgery is emerging, offering real-time data that can support early detection of complications and improve long-term outcomes.

These advancements are expanding the eligible patient base especially younger and more active individuals while also improving long-term cost efficiency by reducing revision rates. As hospitals and health systems prioritize value-based care, demand for technologically superior implants will continue to rise.

Increasing Adoption of Robotic and Navigation-Assisted Surgeries

Robotic-assisted and computer-navigated surgical systems are revolutionizing the precision and consistency of hip arthroplasty procedures.

These systems offer real-time intraoperative data, allowing surgeons to optimize implant placement, leg length, and joint alignment with higher accuracy. Enhanced precision leads to lower complication rates, reduced dislocation risks, and faster patient recovery. Robotic platforms are also being integrated into minimally invasive approaches, further minimizing tissue damage and hospitalization times.

The integration of robotics not only improves surgical outcomes but also enhances surgeon confidence and hospital branding. As more facilities invest in surgical robotics to remain competitive, the demand for hip replacement devices compatible with these systems is expected to grow substantially.

Segmental Insights

Product Insights

Based on the category of Product, the Primary Hip Reconstruction Devices segment emerged as the fastest growing in the market for Hip Replacement Devices in 2024. The incidence of degenerative joint diseases such as osteoarthritis and avascular necrosis is steadily increasing across both developed and developing countries. As the global population ages and lifestyles become more sedentary, the number of patients requiring initial or primary hip reconstruction is surging. This demand is particularly strong in first-time surgical candidates who have reached a stage of functional decline but have not yet undergone previous interventions.

There is a growing clinical trend toward early surgical management of joint degeneration to preserve mobility and enhance long-term quality of life. Surgeons are increasingly recommending primary total hip arthroplasty (THA) at an earlier stage of disease progression. This shift is fueling the need for primary hip reconstruction devices that can offer long-lasting outcomes with fewer post-operative complications. The primary hip reconstruction segment is experiencing significant innovation, particularly in terms of implant materials, fixation techniques, and minimally invasive delivery systems. Modern implants now offer improved wear resistance, better biocompatibility, and greater customization, which not only enhance clinical outcomes but also expand the eligible patient population especially younger and more active individuals. These factors contribute to the growth of this segment.

Download Free Sample Report

Regional Insights

North America emerged as the largest market in the global Hip Replacement Devices market in 2024, holding the largest market share in terms of value. North America, particularly the United States, has a significantly aging population, with a high incidence of osteoarthritis, rheumatoid arthritis, and other degenerative joint diseases. This demographic shift has led to a sustained demand for hip replacement procedures, positioning the region as the largest consumer of hip replacement devices globally.

The region benefits from a well-developed healthcare ecosystem, including access to advanced surgical facilities, skilled orthopedic surgeons, and comprehensive post-operative care systems. Favorable reimbursement frameworks provided by private insurance companies and government programs such as Medicare and Medicaid further support the affordability and adoption of hip replacement surgeries, thereby boosting device sales. North American healthcare providers are early adopters of cutting-edge technologies such as robot-assisted surgery, navigation systems, and 3D-printed implants. This trend has spurred demand for next-generation hip replacement devices that offer greater precision, shorter recovery times, and improved long-term outcomes. Major device manufacturers often launch or pilot their newest technologies in North America due to its high-value market and regulatory maturity.

Recent Developments

• In October 2024, CytexOrtho announced today that it has received FDA clearance to initiate a Phase 1 clinical trial for its novel absorbable hip implant, aimed at evaluating safety and preliminary efficacy in human subjects. The company’s ReNew Hip Implant leverages advanced 3D fabrication technologies and a proprietary formulation of polycaprolactone (PCL), a bioresorbable polymer. Unlike traditional implants, this device is specifically engineered for patients with early-stage hip disease who are not yet candidates or are seeking to delay the need for a total hip replacement. The implant is intended to promote joint preservation by supporting natural bone and cartilage regeneration, potentially extending the functional life of the native hip joint.
• In October 2024, OrthAlign, Inc., a privately held medical device innovator, has received FDA 510(k) clearance for its Lantern Hip system an advanced handheld navigation technology tailored for direct anterior total hip arthroplasty performed with the patient in the supine position. Lantern Hip expands the company's growing Lantern platform, which already includes precision-guided solutions for total knee, revision knee, and partial knee arthroplasty. This new application is engineered to deliver real-time, intraoperative guidance to surgeons during hip replacement procedures, aiming to enhance component alignment accuracy and procedural consistency without the need for large console-based systems.
• In July 2024- Smith+Nephew announced today that it has secured FDA 510(k) clearance for its Catalystem Primary Hip System, a next-generation solution designed to support reproducible outcomes in primary hip arthroplasty. The Catalystem integrates streamlined instrumentation with modern implant design to enhance surgical efficiency and accommodate evolving surgeon techniques. The system reflects Smith+Nephew’s strategic focus on innovation in joint reconstruction by offering solutions that improve workflow without compromising precision or patient outcomes.

Key Market Players

• Johnson & Johnson (DePuy Synthes)
• B. Braun Melsungen AG
• Stryker Corporation
• Zimmer Biomet Holdings Inc
• Corin Group
• Waldemar LINK GmbH & Co. KG
• MicroPort Scientific Corporation
• Exactech, Inc.
• Conformis Inc.
• OMNIlife Science Inc

Report Scope:

In this report, the Global Hip Replacement Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Hip Replacement Devices Market, By Product Type:

o   Primary Hip Reconstruction Devices

o   Partial Hip Reconstruction Devices

o   Revision Hip Reconstruction Devices

o   Hip Resurfacing Devices

• Hip Replacement Devices Market, By End User:

o   Hospitals

o   Ambulatory Care Centers

o   Orthopedics Clinics

o   Others

• Hip Replacement Devices Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hip Replacement Devices Market.

Available Customizations:

Global Hip Replacement Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).